Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome.

Clark S, Schwalbe J, Stasko MR, Yarowsky PJ, Costa AC.

Exp Neurol. 2006 Jul;200(1):256-61. Epub 2006 Apr 19.

PMID:
16624293
2.

Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.

Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, Grossi G, Fernandez M, Giuliani A, Calzà L, Bartesaghi R.

J Neurosci. 2010 Jun 30;30(26):8769-79. doi: 10.1523/JNEUROSCI.0534-10.2010.

3.

Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome.

Guidi S, Stagni F, Bianchi P, Ciani E, Ragazzi E, Trazzi S, Grossi G, Mangano C, Calzà L, Bartesaghi R.

Brain Pathol. 2013 Mar;23(2):129-43. doi: 10.1111/j.1750-3639.2012.00624.x. Epub 2012 Sep 3.

PMID:
22817700
4.

Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.

Stagni F, Magistretti J, Guidi S, Ciani E, Mangano C, Calzà L, Bartesaghi R.

PLoS One. 2013 Apr 19;8(4):e61689. doi: 10.1371/journal.pone.0061689. Print 2013.

5.

Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.

Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, Bartesaghi R, Ciani E.

Hippocampus. 2007;17(8):665-78.

PMID:
17546680
6.

Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.

Stagni F, Giacomini A, Guidi S, Ciani E, Ragazzi E, Filonzi M, De Iasio R, Rimondini R, Bartesaghi R.

Neurobiol Dis. 2015 Feb;74:204-18. doi: 10.1016/j.nbd.2014.12.005. Epub 2014 Dec 10.

PMID:
25497735
7.

Lithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndrome.

Bianchi P, Ciani E, Contestabile A, Guidi S, Bartesaghi R.

Brain Pathol. 2010 Jan;20(1):106-18. doi: 10.1111/j.1750-3639.2008.00246.x. Epub 2009 Mar 3.

PMID:
19298631
8.

Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for Down syndrome.

Contestabile A, Fila T, Bartesaghi R, Ciani E.

Brain Pathol. 2009 Apr;19(2):224-37. doi: 10.1111/j.1750-3639.2008.00168.x. Epub 2008 May 14.

PMID:
18482164
9.

Hippocampal hypocellularity in the Ts65Dn mouse originates early in development.

Lorenzi HA, Reeves RH.

Brain Res. 2006 Aug 9;1104(1):153-9. Epub 2006 Jul 7.

PMID:
16828061
10.

Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells.

Wu X, Castrén E.

Biol Psychiatry. 2009 Jul 1;66(1):5-8. doi: 10.1016/j.biopsych.2009.01.023. Epub 2009 Feb 28.

PMID:
19251245
11.

Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome.

Llorens-Martín MV, Rueda N, Tejeda GS, Flórez J, Trejo JL, Martínez-Cué C.

Neuroscience. 2010 Dec 29;171(4):1228-40. doi: 10.1016/j.neuroscience.2010.09.043. Epub 2010 Sep 26.

PMID:
20875841
12.

Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.

Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, Moldrich R, Kurniawan N, Mardon K, Giuliani A, Calzà L, Bartesaghi R.

Brain. 2014 Feb;137(Pt 2):380-401. doi: 10.1093/brain/awt340. Epub 2013 Dec 12.

PMID:
24334313
13.

Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment.

Beauquis J, Roig P, Homo-Delarche F, De Nicola A, Saravia F.

Eur J Neurosci. 2006 Mar;23(6):1539-46.

PMID:
16553617
14.
15.

Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine.

Cowen DS, Takase LF, Fornal CA, Jacobs BL.

Brain Res. 2008 Sep 4;1228:14-9. doi: 10.1016/j.brainres.2008.06.059. Epub 2008 Jun 24.

PMID:
18616933
16.

Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome.

Bianchi P, Bettini S, Guidi S, Ciani E, Trazzi S, Stagni F, Ragazzi E, Franceschini V, Bartesaghi R.

Exp Neurol. 2014 Jan;251:1-11. doi: 10.1016/j.expneurol.2013.10.018. Epub 2013 Nov 2.

PMID:
24192151
17.

Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome.

Martínez-Cué C, Martínez P, Rueda N, Vidal R, García S, Vidal V, Corrales A, Montero JA, Pazos Á, Flórez J, Gasser R, Thomas AW, Honer M, Knoflach F, Trejo JL, Wettstein JG, Hernández MC.

J Neurosci. 2013 Feb 27;33(9):3953-66. doi: 10.1523/JNEUROSCI.1203-12.2013.

18.

Growth hormone signaling and hippocampal neurogenesis: insights from genetic models.

Ransome MI, Turnley AM.

Hippocampus. 2008;18(10):1034-50. doi: 10.1002/hipo.20463.

PMID:
18566962
19.

Gender and endogenous levels of estradiol do not influence adult hippocampal neurogenesis in mice.

Lagace DC, Fischer SJ, Eisch AJ.

Hippocampus. 2007;17(3):175-80.

PMID:
17286277
20.

Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke.

Li WL, Cai HH, Wang B, Chen L, Zhou QG, Luo CX, Liu N, Ding XS, Zhu DY.

J Neurosci Res. 2009 Jan;87(1):112-22. doi: 10.1002/jnr.21829.

PMID:
18711744

Supplemental Content

Support Center